Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010;9:767 775. doi: 10.1016/S1474-4422(10)70163-0 248. He J, Zhang Y, Xu T, Zhao Q, Wang D, Chen CS, Tong W, Liu C, Xu T, Ju Z, et al; CATIS Investigators. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. JAMA. 2014;311:479 489. 249. ENOS Trial Investigators, Bath PM, Woodhouse L, Scutt P, Krishnan K, Wardlaw JM, Bereczki D, Sprigg N, Berge E, Beridze M, Caso V, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treat- ment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet. 2015;385:617 628. 250. Kaste M, Fogelholm R, Eril T, Palom ki H, Murros K, Rissanen A, Sarna S.A randomized, double-blind, placebo-controlled trial of nimodip- ine in acute ischemic hemispheric stroke. Stroke. 1994;25:1348 1353. 251. Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T. The Intravenous Nimodipine West European Trial (INWEST) of nimodip- ine in the treatment of acute ischemic stroke. Cerebrovasc Dis. 1994;4:204 210. 252. Eveson DJ, Robinson TG, Potter JF. Lisinopril for the treatment of hyper- tension within the first 24 hours of acute ischemic stroke and follow-up. Am J Hypertens. 2007;20:270 277. doi: 10.1016/j.amjhyper.2006.08.005 253. Bath PM, Martin RH, PaleschY, Cotton D,Yusuf S, Sacco R, Diener HC, Toni D, Estol C, Roberts R; for the PRoFESS Study Group. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. 254. 